Tempus AI, Inc.

Tempus AI, Inc. is a leading healthcare technology company dedicated to transforming precision medicine through data-driven insights and advanced diagnostics. The company leverages artificial intelligence and machine learning to analyze vast amounts of clinical, molecular, and imaging data, providing critical information to healthcare providers, pharmaceutical companies, and researchers. Its core offerings include next-generation sequencing diagnostics, polymerase chain reaction profiling, and molecular genotyping, enabling more accurate and personalized patient care, particularly in oncology. Tempus also provides a comprehensive data library called Insights, which links de-identified clinical, molecular, and imaging data, alongside analytical tools and cloud-based computing services for its partners in the pharmaceutical and biotechnology sectors. Furthermore, the company facilitates clinical trial matching through its Trials service and offers specialized algorithmic tests in oncology via Next and Algos. Its integrated platforms, Hub and Lens, streamline test ordering, management, and data analysis for both clinicians and researchers. Tempus actively pursues strategic collaborations with industry leaders to accelerate the development of novel therapeutics and diagnostic solutions, positioning itself at the forefront of innovation in the rapidly evolving landscape of personalized healthcare.